Filter your search
Biotechnology markets include the tools, consumables, services and intellectual property necessary for life sciences and applied medical research. The products of such research include biopharmaceuticals, vaccines, and other biologics. Emerging markets like that of mass spectrometry used in clinical testing applications highlight technological advances that urge more companies to make deals in the field of biotechnology. As the industry grows, companies will develop and integrate automated platforms and diagnostic kits that greatly increase convenience and reliability. This efficiency-mindedness had permeated the past decade in the biotechnology field, as the pace and breadth of translational or biomedical research has created multi-billion dollar markets for research tools and services as well as for the discovered and subsequently marketed biologics. In the future, companies hope to see convenient clinical diagnostic applications eventually coming into multiple areas of the clinical lab.
Next Generation Sequencing
Proteomics
Biopharmaceuticals
Instrumentation & Equipment
Emerging Technologies
- More than 42,000 Instruments at over 5,000 Facilities across a Dozen Modalities — 12 Month License with Quarterly Refresh Download Brochure The most comprehensive database of installed clinical diagnostic equipment in the U.S. The Kalorama Information MasterFile contains detailed information on more than 5,300 hospitals and testing facilities and over 42,000 clinical diagnostic instruments across 12 […]August 30, 2021$4,000 – $8,000The Market for Library Preparation and Target Enrichment for Next-Generation Sequencing This report, Market for Library Preparation and Target Enrichment for Next-Generation Sequencing (NGS) examines the current market, providing a comprehensive market summary, including NGS sample preparation revenues and growth rates for 2021-2026 and NGS sample preparation revenues by geographic region for 2020 (North America, […]July 28, 2021$2,200 – $30,000From Science and Medicine Group, the owners of the popular INSTRUMENT BUSINESS OUTLOOK, comes a new twice-a-month newsletter dedicated to cell and gene therapy. Cell and Gene Therapy Business Outlook offers the following: Market Sizing and Forecasting of CAGT Markets: Each issue sizes up the market opportunity and projects the future revenues for a given therapeutic […]Twice Monthly | 20+ Pages$5,500 – $11,000The study of individual cells has long been an important part of biological research. Historically this has been a very manual process; some automated technologies are available. The need for microscopy and other traditional methods has remained, as new methods have also arrived, all of which have been gradually improved. The ability to amplify DNA […]December 23, 2020$5,500 – $11,000The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of […]August 24, 2020$4,000 – $8,000CLICK HERE TO VIEW NEW VERSION OF THIS REPORT The current COVID-19 crisis affecting the United States and the world has caused hundreds of thousands of deaths and countless economic costs. This has brought forth an array of solutions that could contribute to detecting, containing and possibly treating the disease. Kalorama Information has covered the […]May 14, 2020$5,500 – $11,000Outsourcing drug discovery is the beginning phase of the drug development process. Through outsourcing portions of their drug discovery programs, many pharmaceutical and biotechnology companies have found an effective cost-cutting strategy that can also improve the hit-to-lead conversion and early identification of unsuccessful compounds. In view of the fact that outsourcing can accelerate the drug […]May 8, 2020$5,500 – $11,000What is the Size of the Cell and Gene Therapy Market? According to the latest report on the cell and gene therapy market from Kalorama Information, the global market for cell and gene therapy in 2020 is estimated to reach $3,866 million And most of the market is for the treatment of cancer. Dermatological, Cardiovascular […]April 27, 2020The vaccine market is poised for a rather substantial increase in the next five years due to the number of vaccines in development and the push for a COVID-19 vaccine. As the COVID-19 outbreak advanced worldwide, companies stepped up to the challenge, scrambling to provide a potential vaccine. In addition to discussion of COVID-19 vaccine […]April 21, 2020$750 – $1,000For years, Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most […]April 7, 2020
